Dietary paradox in Southern Europe where healthy diets coexist with rising diabetes rates, puzzling researchers.
Boehringer Ingelheim's obesity drug trial results show a 13.1% weight loss, a disappointing outcome in the competitive market dominated by Eli Lilly…